Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole

Clinical trial NCT02219009 · COMPLETED

Trial details

NCT number: NCT02219009
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Mental Disorder Nervous System Diseases

Start date: 2014-08-01
Primary completion: 2015-07-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.